Product Information
GNP TUSSIN MUCUS-CON 200 MG/10 is a generic product labeled by AmerisourceBergen, priced at $0.0229 per ML under NDC 46122078529. Its NADAC has been published 76 times since Apr 23, 2025.
Strength
200 mg/10mL
Manufacturer
AmerisourceBergenNDC
46122078529
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/24/2024
Pharmacological Classes
Price Statistics
The NADAC for GNP TUSSIN MUCUS-CON 200 MG/10 has been published 76 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0229 per ML |
|---|---|
| All-time high | $0.0233 (May 14, 2025) |
| All-time low | $0.0211 (Sep 17, 2025) |
| 52-week high | $0.0229 |
| 52-week low | $0.0211 |
| Median price | $0.0222 |
| Average price | $0.0221 |
| Largest weekly change | -3.4% (May 21, 2025) |
| Weeks tracked | 76 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP TUSSIN MUCUS-CON 200 MG/10?
The current National Average Drug Acquisition Cost (NADAC) for GNP TUSSIN MUCUS-CON 200 MG/10, manufactured by AmerisourceBergen, is $0.0229 per ML (NDC 46122078529), effective Sep 30, 2026.
How has the price of GNP TUSSIN MUCUS-CON 200 MG/10 changed over time?
Over the history we have for it, the NADAC for GNP TUSSIN MUCUS-CON 200 MG/10 has held within roughly two percent of its current level. It has been tracked across 76 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for GNP TUSSIN MUCUS-CON 200 MG/10?
Since Apr 23, 2025, the NADAC for GNP TUSSIN MUCUS-CON 200 MG/10 has ranged from a low of $0.0211 (Sep 17, 2025) to a high of $0.0233 (May 14, 2025), with a median of $0.0222 per ML.
Are there cheaper alternatives to GNP TUSSIN MUCUS-CON 200 MG/10?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GNP TUSSIN MUCUS-CON 200 MG/10, is $0.0182 per ML — about 21% below GNP TUSSIN MUCUS-CON 200 MG/10.
Who manufactures GNP TUSSIN MUCUS-CON 200 MG/10?
GNP TUSSIN MUCUS-CON 200 MG/10 (NDC 46122078529) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.